NanoVation Therapeutics Inc. logo

NanoVation Therapeutics Inc.

6 Marks
Corp.
First Filed:Jul 17, 2022Latest Filed:Feb 9, 2025Address:2665 East Mall, Vancouver, V6T1Z4, CA

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
6(100%)
Class 42
Software, IT Services & Scientific Research
4(67%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

6 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
NVTX
NVTX
Trademark
Word
PENDING
Owner:
Serial:99034278
Filed:Feb 9, 2025
Classes:5, 42
Description: Drug delivery agents in the form of lipid nanoparticles that facilitate the delivery of pharmaceutical preparations; Nucleic acids for medical or veterinary purposes; Research and development services of new pharmaceutical products; Research and development services in the field of pharmaceutical preparations; Pharmaceutical drug development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Pharmaceutical products development; Development of pharmaceutical preparations and medicines
DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY
Owner:
Serial:98090566
Filed:Jul 18, 2023
Classes:5
Description: Lipid-based delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of nucleic acid for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders associated with aging
LCLNP
LCLNP
Trademark
Word
REGISTERED
Owner:
Serial:79352347
Filed:Jul 18, 2022
Classes:5
Registration:7393905
Registered:May 28, 2024
Description: Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging | Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
NANOVATION GENERATORS
PENDING
Owner:
Serial:97506779
Filed:Jul 17, 2022
Classes:5, 42
Description: Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
NANOVATION THERAPEUTICS
PENDING
Owner:
Serial:97506764
Filed:Jul 17, 2022
Classes:5, 42
Description: Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; "THERAPEUTICS"; Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
NANOVATIONTX
NANOVATIONTX
Trademark
Word
PENDING
Owner:
Serial:97506782
Filed:Jul 17, 2022
Classes:5, 42
Description: Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services